Frontage Holdings Corporation (1521.HK)

HKD 1.17

(3.54%)

EBITDA Summary of Frontage Holdings Corporation

  • Frontage Holdings Corporation's latest annual EBITDA in 2023 was 45.01 Million USD , up 5.75% from previous year.
  • Frontage Holdings Corporation's latest quarterly EBITDA in 2024 Q2 was 16.5 Million USD , down 0.0% from previous quarter.
  • Frontage Holdings Corporation reported an annual EBITDA of 54.1 Million USD in 2022, up 27.11% from previous year.
  • Frontage Holdings Corporation reported an annual EBITDA of 42.56 Million USD in 2021, up 83.46% from previous year.
  • Frontage Holdings Corporation reported a quarterly EBITDA of 24.67 Million USD for 2023 Q4, down 0.0% from previous quarter.
  • Frontage Holdings Corporation reported a quarterly EBITDA of 20.34 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Frontage Holdings Corporation (2023 - 2016)

Historical Annual EBITDA of Frontage Holdings Corporation (2023 - 2016)

Year EBITDA EBITDA Growth
2023 45.01 Million USD 5.75%
2022 54.1 Million USD 27.11%
2021 42.56 Million USD 83.46%
2020 23.2 Million USD 23.55%
2019 18.77 Million USD -0.5%
2018 18.87 Million USD -13.42%
2017 21.79 Million USD 56.49%
2016 13.92 Million USD 0.0%

Peer EBITDA Comparison of Frontage Holdings Corporation

Name EBITDA EBITDA Difference
Uni-Bio Science Group Limited 91.23 Million HKD 50.655%
CK Life Sciences Int'l., (Holdings) Inc. 486.79 Million HKD 90.752%